Business Description
Duality Biotherapeutics is a Shanghai-based company founded in 2019 that develops targeted cancer treatments known as antibody-drug conjugates, which are designed to deliver therapy directly to cancer cells while minimizing harm to healthy tissue. The company has several drug candidates in clinical trials, including treatments aimed at breast cancer, lung cancer, prostate cancer, and other tumor types. Duality works alongside major partners such as BioNTech and BeOne to advance its therapies toward patients in China and around the world.
